XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research & development 428,748 343,133 1,650,281 619,174
General & administrative 841,614 446,977 2,000,011 1,192,810
Facility 103,505 99,086 352,476 314,901
Insurance 94,629 81,219 287,309 243,120
Total expenses 1,568,496 970,415 4,290,077 2,370,005
Loss from operations (1,568,496) (970,415) (4,290,077) (2,370,005)
Other income:        
Sub-lease rental income & other income 107,426 55,689 217,942 227,589
Interest income 269 349 744 1,694
Total other income 107,695 56,038 218,686 229,283
Loss before income tax expense (1,460,801) (914,377) (4,071,391) (2,140,722)
Income tax expense
Net loss $ (1,460,801) $ (914,377) $ (4,071,391) $ (2,140,722)
Basic and diluted loss per share (in Dollars per share) $ (0.13) $ (0.09) $ (0.37) $ (0.2)
Weighted average common shares outstanding - basic and diluted (in Shares) 11,518,154 10,650,002 10,983,045 10,650,002